Praxis Biologics Inc> file registration statement Securities Exchange Commission initial offering 1.5 mln share common. It offering manage Shearson Lehman Brothers Inc Merrill Lynch Capital Markets. Praxis proceeds fund product research development cost initially focus vaccine infant children. Reuter 